MIMETIBODY

Welcome to the Brand page for “MIMETIBODY”, which is offered here for Pharmaceutical composition, small peptide or protein fused with an antibody or antibody fragment for use in the treatment of cancer, renal failure, anemia, cardiovascular disease, metabolic disease, immune and inflammatory diseases, and infectious diseases;.

Its status is currently believed to be active. Its class is unavailable. “MIMETIBODY” is believed to be currently owned by “Johnson & Johnson”.

Owner:
JOHNSON & JOHNSON
Owner Details
Description:
Pharmaceutical composition, small peptide or protein fused with an antibody or antibody fragment for use in the treatment of cancer, renal failure, anemia, cardiovascular disease, metabolic disease, immune and inflammatory diseases, and infectious diseases;
Categories: PHARMACEUTICAL COMPOSITION